Related Experiment Video

Updated: Aug 25, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Management of chronic hepatitis B and C virus infections

Voranush Chongsrisawat1, Yong Poovorawan

  • 1Viral Hepatitis Research Unit, Department of Pediatrics, Chulalongkorn University & Hospital, Bangkok, Thailand.

Indian Journal of Pediatrics
|April 4, 2002
PubMed

Insights

Treating chronic Hepatitis B virus (HBV) and Hepatitis C virus (HCV) in children aims to reduce liver inflammation and long-term risks. Current treatments show promise, but long-term effects in pediatric patients require further evaluation.

Area of Science:

  • Hepatology
  • Virology
  • Pediatric Infectious Diseases

Background:

  • Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections pose significant global health challenges, particularly in children, increasing risks of chronic infection and severe outcomes.
  • Chronic HBV and HCV infections in children can lead to hepatic inflammation, hepatocellular carcinoma, and reduced survival rates.
  • Effective treatment strategies are crucial for managing pediatric viral hepatitis, aiming to mitigate disease progression and improve patient prognosis.

Purpose of the Study:

  • To review the current understanding of treating chronic HBV and HCV infections in children.
  • To evaluate the efficacy and long-term benefits of antiviral therapies in pediatric populations.
  • To identify gaps in knowledge regarding the long-term clinical and virological effects of treatments in children.

Main Methods:

  • Literature review of studies on antiviral treatments for chronic HBV and HCV in pediatric patients.
  • Analysis of data on the effectiveness of Interferon (IFN) in children with chronic HBV infection.
  • Examination of available information on lamivudine and combination therapies (IFN and ribavirin) for pediatric viral hepatitis.

Main Results:

  • Interferon (IFN) therapy can accelerate the natural course of chronic HBV infection in children with high disease activity and low viral replication.
  • Limited data exists on the long-term benefits of lamivudine for children with chronic HBV infection.
  • The efficacy of combination therapy with IFN and ribavirin for chronic HCV infection in children is still under investigation.

Conclusions:

  • Antiviral therapies offer potential benefits in managing chronic HBV and HCV in children by reducing inflammation and associated risks.
  • Further research is essential to fully understand the long-term clinical and virological outcomes of various drug regimens in pediatric patients with chronic viral hepatitis.
  • Long-term monitoring and evaluation of treatment effects are critical for optimizing pediatric viral hepatitis management.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...